Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucinactant for Mucociliary Clearance in Cystic Fibrosis
NCT00934362Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Oct 2008
- Primary completion
- Aug 2010
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of lucinactant in cystic fibrosis (CF), sponsored by University of North Carolina at Chapel Hill. Started Oct 2008; status: completed.
02
Drugs
lucinactant
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00934362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00934362.